Humanigen Inc (NASDAQ:HGEN) Stock Gains Momentum From Recent Lows
Clinical-stage biopharmaceutical firm Humanigen Inc (NASDAQ:HGEN) is involved in the development of lenzilumab, which is the first antigen in its…
Clinical-stage biopharmaceutical firm Humanigen Inc (NASDAQ:HGEN) is involved in the development of lenzilumab, which is the first antigen in its…